Stromal Interferon Regulatory Factor 3 Can Antagonize Human Papillomavirus Replication by Supporting Epithelial-to-Mesenchymal Transition
Viruses · 2025
DOI: 10.3390/v17050598 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Oluwamuyiwa T Amusan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Louisiana State University Health Sciences Center-Shreveport, 1501 Kings Highway, Shreveport, LA 71103, US…. Hauptthemen laut MEDLINE: Interferon Regulatory Factor-3, Epithelial-Mesenchymal Transition, Virus Replication, Human papillomavirus 16. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Science and Medicine Academic Research Training (SMART) program, Feist-Weiller Cancer Center.
Abstract (Originalsprache)
Epithelia contribute to the innate immune system through barrier formation and through signaling to immune cells. When the barrier is breached, epithelial cells undergo epithelial-to-mesenchymal transition (EMT) as part of the wound healing process. EMT is largely directed by signals from the stromal microenvironment, including transforming growth factor beta (TGFβ1), and antagonizes normal epithelial differentiation. How EMT and innate immunity may be connected molecularly has not been explored, although both processes are likely to occur simultaneously. Keratinocytes are the host cell type for human papillomaviruses (HPV), which can induce EMT in certain conditions but also depend on differentiation for their replication. We previously found that the innate immune factor interferon regulatory factor 3 (IRF3) inhibits epithelial differentiation and reduces the expression of HPV16 late genes. Here we report that IRF3 in the stroma compartment promotes an EMT-like pattern of gene expression in an HPV16-containing epithelium. The depletion of stromal IRF3 resulted in the downregulation of TGFβ1-related signaling in both the stroma and epithelium. IRF3 binds to the TGFB1 promoter in human foreskin fibroblasts and is necessary for TGFB1 mRNA production. Because an EMT-like state is unfavorable for differentiation-dependent HPV16, we observed that all EMT markers examined were reduced in the presence of episomal HPV16. Together, we show that stromal IRF3 can disrupt epithelial differentiation and act as an anti-HPV factor through the regulation of EMT, linking wound healing and immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Louisiana State University Health Sciences Center-Shreveport, 1501 Kings Highway, Shreveport, LA 71103, USA.
ORCID-Profile: Elijah Burks, Jason Bodily
Förderung
- NIH HHS
- Science and Medicine Academic Research Training (SMART) program
- Feist-Weiller Cancer Center
- NIGMS NIH HHS
- NCI NIH HHS
- NIAID NIH HHS
- LSUHS Center for Emerging Viral Threats
- NIH
Zitieren
APA
Amusan, O. T., Lopez, R., Burks, E., Trammel, J., Raikhy, G., Guo, H., & Bodily, J. (2025). Stromal Interferon Regulatory Factor 3 Can Antagonize Human Papillomavirus Replication by Supporting Epithelial-to-Mesenchymal Transition. Viruses. https://doi.org/10.3390/v17050598
Vancouver
Amusan OT, Lopez R, Burks E, Trammel J, Raikhy G, Guo H, et al. Stromal Interferon Regulatory Factor 3 Can Antagonize Human Papillomavirus Replication by Supporting Epithelial-to-Mesenchymal Transition. Viruses. 2025. doi:10.3390/v17050598
BibTeX
@article{Amusan2025,
author = {Amusan, Oluwamuyiwa T and Lopez, Rebecca and Burks, Elijah and Trammel, Jessica and Raikhy, Gaurav and Guo, Hongyan and Bodily, Jason},
title = {Stromal Interferon Regulatory Factor 3 Can Antagonize Human Papillomavirus Replication by Supporting Epithelial-to-Mesenchymal Transition},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17050598}
}
EUVIMED